Chronic low back pain has a way of narrowing your life quietly. You stop lifting things a certain way. You skip the activities that used to feel routine. Physical therapy helps, then helps less. An injection buys you a few good months. At some point, most patients start asking whether there is another option, something short of spinal fusion that addresses the disc itself rather than only managing the pain.

Degenerative disc disease (DDD) is the gradual breakdown of the cushioning discs between your vertebrae. It’s a leading cause of chronic low back pain, and unlike a muscle strain, it doesn’t resolve on its own. This is where UC-MSC therapy has entered the conversation as an option worth understanding.

What causes disc degeneration, and why is it hard to treat?

Each spinal disc has a soft, gel-like center surrounded by a tougher outer ring. Over time, age, repeated strain, or injury can cause the disc to lose hydration and height, while the outer ring may weaken or tear. These changes reduce the disc’s ability to cushion and support the spine, which can contribute to chronic pain.

Discs are one of the least accessible tissues in the body to treat directly. They have almost no blood supply, which is part of why they degenerate in the first place, and why they don’t repair themselves the way other tissues can. Standard treatment options such as physical therapy, anti-inflammatory medication, epidural injections. They manage the symptoms without changing the underlying condition. When these stop working well enough, the next step has traditionally been spinal fusion surgery, which is effective but irreversible and changes how the spine moves permanently.

How UC-MSCs work for disc degeneration

UC-MSCs are stem cells collected from donated umbilical cord tissue. When introduced into a degenerating disc, they work mainly through signalling rather than by physically rebuilding disc tissue. They release anti-inflammatory and repair-supporting factors that calm the damaged disc environment, help preserve the remaining disc cells, and support the disc’s own capacity to maintain its structure.

This isn’t disc replacement. It’s an attempt to change the biological environment inside a disc that’s already stuck in a degenerative cycle, with the goal of reducing pain and slowing further breakdown.

What the evidence shows

Research on stem cell therapy for disc degeneration has grown substantially over the past decade. Multiple studies pooling results across patients have found meaningful reductions in pain and improved function following stem cell injection into the affected disc, with benefits reported to last a year or more in many patients. Some studies have also found improvements in disc hydration on imaging, suggesting the treatment may affect the disc itself rather than just masking pain.

The safety profile across available studies has been favorable, with no major safety concerns reported and side effects generally limited to mild, temporary discomfort at the injection site.

Who might be a reasonable candidate?

Patients with mild to moderate disc degeneration who haven’t responded adequately to physical therapy, medication, or injections, but don’t yet have severe structural collapse or nerve compression requiring urgent surgery tend to be the more reasonable candidates. Patients with significant spinal instability, active infection, or certain other spinal conditions may not be appropriate candidates, and a full evaluation including imaging is necessary before any treatment decision.

What to realistically expect

This is not a cure, and it doesn’t reverse years of disc degeneration. What the evidence supports is a meaningful reduction in pain and improved function for many patients, developing over weeks to months rather than immediately. For patients trying to avoid or delay spinal fusion, it’s a reasonable option to discuss with a specialist and it is not a guaranteed alternative to surgery for everyone.

Medically reviewed by Dr. Pongwat Polpong, M.D.
Neurosurgeon, Chief Physician at EDNA Wellness

FAQ

Can stem cell therapy fix a degenerated disc?

No. It doesn’t reverse existing disc damage or restore a disc to its original state. It may reduce pain and inflammation and support the disc’s remaining function.

How long do the effects last?

Reported benefits have lasted a year or more in many patients who respond, though results vary.

Is stem cell therapy an alternative to spinal fusion?

For some patients with earlier-stage disc degeneration, it may help delay or avoid fusion. It isn’t a substitute for surgery in cases of severe structural damage or nerve compression.

Is it safe?

Reported safety has been favorable across available studies, with side effects generally limited to mild, temporary discomfort at the injection site.

Who shouldn’t get this treatment?

Patients with significant spinal instability, active infection, or certain other spinal conditions are generally not candidates. A full medical evaluation is required.

About EDNA Wellness

EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord–Derived Mesenchymal Stem Cells (UC-MSCs).

All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.

For more information or to book a consultation:

LINE: @ednawellness

WhatsApp: +66 (0) 64 505 5599

www.ednawellness.com

References

• Xie B, Chen S, Xu Y, et al. Clinical Efficacy and Safety of Human Mesenchymal Stem Cell Therapy for Degenerative Disc Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Stem Cells Int. 2021;2021:9149315. https://pmc.ncbi.nlm.nih.gov/articles/PMC8455197/
• Zhang W, Wang D, Li H, et al. Mesenchymal stem cells can improve discogenic pain in patients with intervertebral disc degeneration: a systematic review and meta-analysis. Front Bioeng Biotechnol. 2023;11:1155357. https://pmc.ncbi.nlm.nih.gov/articles/PMC10313064/
• Pang X, Yang H, Peng B. Human umbilical cord mesenchymal stem cell transplantation for the treatment of chronic discogenic low back pain. Pain Physician. 2014;17(4):E525-E530. https://pubmed.ncbi.nlm.nih.gov/25054402/